BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 11848652)

  • 21. Imaging of paediatric liver tumours with pathological correlation.
    Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
    Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 42-year-old woman with liver masses and long-term use of oral contraceptives.
    Ye MQ; Suriawinata A; Ben Haim M; Parsons R; Schwartz ME
    Semin Liver Dis; 1999; 19(3):339-44. PubMed ID: 10518313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphoma-simulating presentation of focal nodular hyperplasia (FNH) of the liver].
    Schmitz D; Köhler HH; Heussel CP; Löhr HF; Galle PR
    Z Gastroenterol; 2001 Mar; 39(3):219-24. PubMed ID: 11324139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Focal nodular hyperplasia, hepatocellular adenoma and hormonal contraceptives].
    Corboz A
    Schweiz Rundsch Med Prax; 1983 Feb; 72(6):177-82. PubMed ID: 6300822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute abdomen as form of presentation of hepatic adenoma].
    Sambresqui A; Bilder C; Viola L; Fernández JL; Díaz Stefani G; Domenichini E; Morgante P
    Acta Gastroenterol Latinoam; 1988; 18(4):269-74. PubMed ID: 3076313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-orientated approach to the management of hepatocellular adenoma.
    van der Windt DJ; Kok NF; Hussain SM; Zondervan PE; Alwayn IP; de Man RA; IJzermans JN
    Br J Surg; 2006 Dec; 93(12):1495-502. PubMed ID: 17051603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differential diagnosis between hepatic focal nodular hyperplasia and hepatocellular carcinoma with negative alhpa-fetoprotein].
    Ye Q; Tang Z; Ma Z; Wu Z; Fan J; Qin L; Wang W
    Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):136-8. PubMed ID: 10880157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases].
    Li AJ; Zhou WP; Wu MC
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):321-3. PubMed ID: 16635391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiology disease of rare liver tumors (author's transl)].
    Bosnjakovic S; Barth V; Heuck F
    Radiologe; 1980 Jul; 20(7):355-64. PubMed ID: 6248922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rupture and hemorrhage of hepatic focal nodular hyperplasia.
    Becker YT; Raiford DS; Webb L; Wright JK; Chapman WC; Pinson CW
    Am Surg; 1995 Mar; 61(3):210-4. PubMed ID: 7887531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.
    Korula J; Yellin A; Kanel G; Campofiori G; Nichols P
    West J Med; 1991 Oct; 155(4):416-8. PubMed ID: 1663298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
    Bedi DG; Kumar R; Morettin LB; Gourley K
    Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma as a coincidental finding in a patient undergoing surgery for focal nodular hyperplasia.
    Sotiropoulos GC; Bockhorn M; Molmenti EP; Fouzas I; Broelsch CE; Lang H
    Liver Int; 2008 Apr; 28(4):578-9. PubMed ID: 18339083
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED; Kent DR; Nissen SE
    J Toxicol Environ Health; 1979; 5(2-3):231-54. PubMed ID: 224197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of well-differentiated hepatocellular carcinoma in large adenomatous hyperplasia after long-term follow-up: a case report.
    Midorikawa Y; Ishikawa T; Kubota K; Mori M; Takayama T; Makuuchi M
    Hepatogastroenterology; 2002; 49(46):1098-101. PubMed ID: 12143212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm.
    Dardenne S; Hubert C; Sempoux C; Annet L; Jouret-Mourin A; Horsmans Y; Van Beers BE; Zech F; Gigot JF
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1337-44. PubMed ID: 20683192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver tumors in women using oral hormonal contraceptives].
    Rabe T; Feldmann K; Grunwald K; Runnebaum B
    Zentralbl Gynakol; 1995; 117(3):153-6. PubMed ID: 7740850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)].
    Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W
    Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.